635 related articles for article (PubMed ID: 15301583)
1. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
Kumarasinghe SP; Kumarasinghe MP
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
[No Abstract] [Full Text] [Related]
2. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
3. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
4. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
5. [Leprosy].
Ishii N; Sasaki S
Nihon Rinsho; 2003 Feb; 61 Suppl 2():531-5. PubMed ID: 12722275
[No Abstract] [Full Text] [Related]
6. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
7. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
8. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
9. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
[No Abstract] [Full Text] [Related]
10. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
11. Three years assessment of multidrug therapy in multibacillary leprosy cases.
Ganapati R; Revankar CR; Pai RR
Indian J Lepr; 1987; 59(1):44-9. PubMed ID: 3611860
[TBL] [Abstract][Full Text] [Related]
12. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapy of leprosy: an interpretive history.
Gelber RH; Grosset J
Lepr Rev; 2012 Sep; 83(3):221-40. PubMed ID: 23356023
[No Abstract] [Full Text] [Related]
14. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
15. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
16. [How should leprosy be treated?].
Mahé A
Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
[No Abstract] [Full Text] [Related]
17. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
18. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
19. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]